Celemics

Celemics ROCE

The Return on Capital Employed (ROCE) of Celemics (331920.KQ) as of Oct 23, 2026 is -14.44 %. In the previous year, Return on Capital Employed (ROCE) was -7.00 % — a change of 106.27% (lower).

ROCE

-14.44 %

YoY

106.27%

Last updated:

In 2025, Celemics's return on capital employed (ROCE) was -14.44 %, a 106.27% increase from the -7.00 % ROCE in the previous year.

The Celemics ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
13.65 KRW
Jan 1, 2019
-98.13 KRW
Jan 1, 2020
-16.67 KRW
Jan 1, 2021
-25.74 KRW
Jan 1, 2022
-30.85 KRW
Jan 1, 2023
-36.33 KRW
Jan 1, 2024
-7.00 KRW
Jan 1, 2025
-14.44 KRW
The Celemics ROCE history
YEARROCEYoY
-14.44 %+106.27%
-7.00 %-80.73%
-36.33 %+17.79%
-30.85 %+19.86%
-25.74 %+54.38%
-16.67 %-83.01%
-98.13 %-818.67%
13.65 %-58.85%
33.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics Stock analysis

What does Celemics do? Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry. Celemics is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Celemics's Return on Capital Employed (ROCE)

Celemics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Celemics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Celemics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Celemics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Celemics stock

Return on Capital Employed (ROCE) of Celemics is -14.44 % in 2025.

Return on Capital Employed (ROCE) of Celemics changed from -7.00 % to -14.44 %, representing a 106.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Celemics since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Celemics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Celemics

All Key Metrics — Celemics